Verition Fund Management
HCAT icon

Verition Fund Management’s Health Catalyst HCAT Stock Holding History

Verition Fund Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,841
Closed -$92.8K – 2827
2025
Q4 		$92.8K Sell
38,841
-4,388
-10% -$12K ﹤0.01% 3330
2025
Q3 		$123K Buy
43,229
+178
+0.4% +$609 ﹤0.01% 3570
2025
Q2 		$162K Sell
43,051
-8,802
-17% -$34.6K ﹤0.01% 3411
2025
Q1 		$235K Sell
51,853
-3,502
-6% -$18.5K ﹤0.01% 2984
2024
Q4 		$391K Buy
+55,355
New +$441K ﹤0.01% 2626
2024
Q3 		– Sell
-10,195
Closed -$65.1K – 3321
2024
Q2 		$65.1K Sell
10,195
-1,200
-11% -$7.7K ﹤0.01% 2775
2024
Q1 		$85.8K Buy
+11,395
New +$104K ﹤0.01% 2596

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Verition Fund Management's HCAT Position: Q1 2026 in Review

Verition Fund Management sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 38,841 shares — an estimated $92.8K sold.

Verition Fund Management first reported a position in HCAT in Q1 2024 and held it in 7 quarters. The position peaked at $391K in Q4 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Verition Fund Management reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 38,841 Health Catalyst shares in Q1 2026, an estimated $92.8K.
  • Verition Fund Management first reported a position in Health Catalyst in Q1 2024 and held it in 7 quarters.
  • Verition Fund Management's Health Catalyst position peaked at $391K in Q4 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.